double treatments with LMB and LatB were 15 min with the first drug, followed by 30 minutes with the second drug.
Antibodies and Immunofluorescence
Immunofluorescence microscopy was as described (1-3). 150,000 cells per well in a 6-well dish were transfected with 100 ng of C-terminally HA-tagged, 50 ng of N-terminally FLAG-tagged MAL or 200 ng of MAL-NLS construct. Other constructs are indicated elsewhere. Anti-MAL antibody was from Santa Cruz.
Cells were maintained in medium containing 0.5% serum for 20 h after transfection before stimulation. MAL localization was scored as predominantly nuclear, evenly distributed or predominantly cytoplasmic in 100-200 cells. Data from three independent experiments are shown with SEM.
Live Cell Imaging and Photobleaching
Live-cell imaging was performed essentially as described (4, 5) . Cells were plated on MatTek-dishes (MatTek corporation), and maintained in phenolred free media containing 0.3% serum for 18 hours prior to imaging. Cells were treated with cycloheximide (20 µg/ml) 20 minutes prior to visualization to inhibit protein synthesis. All live cell imaging was performed at 37 o C, in a CO 2 chamber.
Microscopy was performed using an LSM 510 confocal microscope (Zeiss) equipped with an Argon laser. Imaging of GFP was performed with 63X 1.4 NA oil objective using 488 nm excitation and >505 nm longpass filter. Settings were adjusted such that photobleaching due to image acquisition was negligible in all experiments. Images were acquired using the microscope software (Zeiss). For analysis of the nuclear accumulation of MAL upon different stimuli, a stable cell lines expressing MAL-GFP was used. A similar result was also obtained with transient transfection with MAL-GFP. The nuclear fluorescence prior to stimulation was set to zero and nuclear fluorescence after complete accumulation was set to 1. At least 12 cells from three independent movies were analyzed per condition. ) was repeatedly bleached for 80 seconds with 100% laser power (488 nm). An adjacent cell served as a control for bleaching due to image acquisition. For analysis background was subtracted, and nuclear fluorescence prior to bleaching was set to one. At least ten cells from three independent experiments were analyzed per condition.
Photoactivation
For photoactivation (5-7), stable cell lines expressing either PAGFP or MAL-PAGFP were plated on coverslips starved for 18 hours prior to imaging in 0.3% serum containing phenol-red free media. The experiment was carried out at +37 o C. Microscopy was performed using an LSM 510 confocal microscope (Zeiss) equipped with an Argon laser and a Mira 900 multiphoton titaniumsapphire laser (Coherent). Where indicated, cells where stimulated for 30-60 minutes prior to imaging. Photoactivation of the PAGFP was carried out using the bleaching protocol of the software, with the multiphoton laser (approximately 600 mW output) tuned to a wavelength of 820 nm, which approximates 410 nm multiphoton excitation in the focal plane (7). The activation region was chosen to include approximately 75% of the nucleus, and was scanned with 90 % laser power for 5-30 seconds. Imaging of PAGFP after photoactivation was performed with 63X 1.4 NA oil objective using 488 nm excitation and collecting emission using a 500-550 nm bandpass filter. Images were acquired as above. During analysis, background was subtracted, and whole nuclear fluorescence was set to one immediately after photoactivation. At least ten cells from three independent experiments were analyzed per condition. Initial export rates were obtained from early timepoints, where curves could be approximated accurately by an exponential decrease.
Luciferase Reporter Assay
Cells in a 24-well dish (30,000 cells/well) were transfected with SRF reporter p3DA.luc (8 ng), reference reporter ptk-RL (20 ng) with or without SRF-VP16 (40 ng), MAL and MAL mutant derivative (10 ng) or MAL-NLS (20 ng) constructs and maintained in 0.3 or 0.5% serum (FCS) for 15 to 20h. Cells where then stimulated for 7h as indicated, and luciferase activity was measured and normalized for Renilla luciferase activity. For activation of the SRF reporter by MAL2-261-NLS, cells were maintained in 0.5% FBS for 40h. Data of three independent experiments with SEM are expressed relative to reporter activation by co-expressed SRF-VP16.
Chromatin Immunoprecipitation
ChIP assays were as described (2, 8) . SYBR Green based real-time PCR (Invitrogen) on an ABI Prism 7900HT Sequence Detection System (Applied Biosystems) was performed using dilutions of chromatin solution for calibration and to derive arbitrary abundance units. 
Actin Binding Assays
Rabbit skeletal muscle actin was purified and rendered non-polymerizable by modification with TMR (tetramethylrhodamine-5-maleimide) as described (9) (10) (11) . For gel filtration analysis, 10 µM of MAL2-261 and mutant derivatives, For the DNaseI supershift experiment, 30 µM DNaseI (Worthington) was included in the binding reaction. DNaseI forms a 1:1 complex with actin (12) . Drug concentrations were 30 µM SwA (13), 300 µM CD, 60 µM Jasp and 300 µM LatB.
Free polymerizable actin was polymerized by adding 1/20 volume of initiation buffer (2 M NaCl, 60 mM MgCl 2 , 10 mM ATP) and removed by ultracentrifugation (200,000xg; 15 min). Equivalent amounts (1.5 µl) of total sample, supernatant and pellet were subjected to SDS-PAGE and Coomassie brilliant blue staining.
Supernatants were subjected to gel filtration chromatography on a calibrated Superose 12 column (GE Healthcare) in F-buffer (as G-buffer, but with 100 mM NaCl and 3 mM MgCl 2 ) containing 0.2 mM ATP. 30 µM non-polymerizable TMRactin or 10 µM MAL2-261 were used as controls. Eluates were collected in 500 µl fractions of which 10 µl each were resolved by 4-12% SDS-PAGE followed by
Coomassie brilliant blue staining.
For GST pulldown experiments, glutathione-agarose (Sigma) was saturated with GST, GST-MAL2-261 (WT, 123-1A, or 123-2A) from E. coli lysates and used as affinity resin in a binding reaction with total NIH 3T3 cell extract in 50 mM Tris-HCl pH8, 100 mM NaCl, 3 mM MgCl2, 0.2 mM EGTA, 0.5% TX-100, 1 mM DTT and protease inhibitors. The resin was washed 3 times in binding buffer without protease inhibitors and subjected to 4-12% SDS-PAGE and Western blotting against endogenous β-actin (AC-15, Sigma). The blot was stained with
Ponceau to reveal bait input.
Forster Resonance Energy Transfer (FRET) by Fluorescence Lifetime Imaging Microscopy (FLIM)
FRET monitored by FLIM has been described in detail elsewhere (14-16). (B) Quantitation of nuclear accumulation of MAL-GFP in cells stimulated with 0.5 µM Jasplakinolide as described above. Nuclear fluorescence prior to stimulation was set to 0, and nuclear fluorescence after complete accumulation was set to 1. Data show the mean (+/-s.d.) of three independent experiments with a total of 10 cells. Note that nuclear accumulation of MAL-GFP upon jasplakinolide treatment is very similar to accumulation upon CD treatment (see Figure 1C ). Stable NIH 3T3 cell line expressing MAL-GFP was stimulated with 15% serum (FCS) for 30 minutes, after which serum was washed out with media containing 0.3% FCS, or latrunculin B was added to 0.3 µM. Imaging started 2 minutes after serum washout or latrunculin B addition. Nuclear fluorescence at this point was considered as 1. Cytoplasmic re-localization of MAL was monitored by decrease of nuclear fluorescence. In the control experiment, cells were treated with leptomycin B (LMB; 20 nM) for 30 minutes, followed by latrunculin B addition and imaged as above. In this case, nuclear fluorescence remained constant, showing that no bleaching occurred due to image acquisition. Note that the re-distribution of MAL to the cytoplasm upon removal of the signal or blockage of nuclear reimport is a relatively slow process (minutes rather than seconds), suggesting that the export rates do not immediately revert to those seen in unstimulated cells (see Figure 2A ) and that MAL shuttles slower in serum-stimulated than in serum-starved cells (see Figure 1C ). 10 µM purified RPEL domain (MAL2-261) were incubated with 30 µM G-actin with and without drug (LatB, latrunculin B; CD, cytochalasinD; Jasp, jasplakinolide; SwA, swinholide A). Unbound actin was polymerized by salt addition and removed by ultracentrifugation (T, total sample; S, supernatant; P, pellet). Supernatants were gel-filtered on a calibrated Superose 12 column. Eluates were collected in 500 µl fractions and analyzed by SDS-PAGE and Coomassie staining. For analysis of actin alone, actin was modified with TMR (tetramethylrhodamine) on Cys374 to render it nonpolymerizable (11) . Apparent molecular weights, determined via elution volumes, suggest that the RPEL domain binds three actin molecules. Preliminary light scattering data indicate that MAL2-261 is monomeric. MAL2-261 elutes at a higher molecular weight than expected, presumably due to an extended conformation. Note that SwA generates actin dimers (13) . The elution behavior of the small amount of actin retained by MAL-123-2A indicates that an unstable complex formed but dissociated during chromatography. This is not observed for MAL-123-1A, indicating that MAL-123-2A exhibits higher residual affinity for actin than MAL-123-1A. For corroboration of the 1:3 stoichiometry of the MAL-actin complex and analysis of MAL RPEL mutants by GST pulldown, see Figure S7 . 
